Showing results (1781-1790 of 2,362) with videos related to

Sort By:
Pageof 237
Clinical Neuropharmacology|January 22, 2002
Development of parkinsonian symptoms after discontinuation of carbamazepine in patients concurrently treated with risperidone: two case reportsH Takahashi, K Yoshida, H Higuchi, et al.
Clinical Neuropharmacology|February 5, 2003
Topiramate for the treatment of kleptomania: a case series and review of the literaturePinhas N Dannon
Clinical Neuropharmacology|February 5, 2003
Acute delirium, delusion, and depression during IFN-beta-1a therapy for multiple sclerosis: a case reportJ L Goëb, A Cailleau, P Lainé, et al.
Clinical Neuropharmacology|August 2, 2002
Is neuroleptic malignant syndrome a neurogenic form of malignant hyperthermia?Ronald J Gurrera
Clinical Neuropharmacology|August 2, 2002
Antiepileptic drugs in posttraumatic stress disorderIulian Iancu, Yitzhak Rosen, Kotler Moshe
Clinical Neuropharmacology|August 2, 2002
Reversible transvestic fetishism in a man with Parkinson's disease treated with selegilineDavid E Riley
Clinical Neuropharmacology|August 5, 2003
Mirtazapine in L-dopa-induced dyskinesiasGiuseppe Meco, Edito Fabrizio, Simone Di Rezze, et al.
Clinical Neuropharmacology|August 5, 2003
Pharmacokinetic studies of single and multiple oral doses of fampridine-SR (sustained-release 4-aminopyridine) in patients with chronic spinal cord injuryKeith C Hayes, Patrick J Potter, Robert R Hansebout, et al.
Clinical Neuropharmacology|August 5, 2003
Selegiline in the treatment of sexual dysfunction in schizophrenic patients maintained on neuroleptics: a pilot studyArad Kodesh, Abraham Weizman, Dov Aizenberg, et al.
Clinical Neuropharmacology|August 5, 2003
Adjuvant topiramate administration: a pharmacologic strategy for addressing NMDA receptor hypofunction in schizophreniaStephen I Deutsch, Barbara L Schwartz, Richard B Rosse, et al.
Pageof 237